Optimized channel performance by cultivating distributor relationships, executing structured partner evaluations, and streamlining pricing mechanisms across fragmented European markets.
By Eleonora Rabdau, Defne Isler
© Copyright 2025 Eendigo. All Rights Reserved
Pharmaceutical companies in Europe are entering a decisive phase of transformation. Market fragmentation, tender complexity, and distributor consolidation are converging to redefine how value is created in the indirect channel. The distribution landscape, once viewed as a relatively stable enabler of access, has become a decisive lever of performance.
The challenge is structural. Companies have built networks of distributors, wholesalers, and local agents over decades. Many of these partnerships remain vital, but in too many cases they have grown organically rather than strategically. The result is a patchwork of agreements, pricing practices, and governance structures that no longer match today’s reality.
While product portfolios remain strong and demand for generics continues to grow, unchecked inefficiencies in the indirect channel silently erode margins, weaken negotiating positions, and limit agility. Addressing these challenges requires not incremental fixes, but a systematic reframing of how companies manage their partner ecosystems.
Forward-looking leaders are beginning to act. They recognize that partner optimization is not an operational clean-up exercise, but a necessity. The companies that succeed will establish transparency, discipline, and governance across their networks and, in doing so, convert fragmented partner structures into engines of profitable growth.
The Hidden Drain: When Distributor Networks Evolve Without Discipline
At first glance, indirect sales channels may appear to function smoothly. Products move, sales grow, and relationships with distributors provide continuity. Beneath the surface, however, unmanaged networks create multiple performance risks.
Blind spots in partner performance emerge when standardized KPIs are missing. Without them, companies lack visibility into which distributors truly create value. In one case analysis, over 60% of agreements lacked measurable metrics on compliance, margin, or service levels. High-performing partners are not differentiated from underperformers, and decisions rely on intuition rather than fact.
Fragmented go-to-market structures arise as local teams design their own models country by country. The result is overlapping coverage, duplicated effort, and inefficient resource allocation.
Ineffective contracting persists when agreements operate on inherited terms. Many contracts lack clauses tying performance to profitability or incentives aligned with long-term goals. Fewer than 20% of contracts in the reviewed portfolio included measurable performance-linked targets.
Unstructured pricing practices cause further leakage. Discounts, rebates, and incentives vary by market and distributor with little coherence or transparency. Net-to-gross leakage of 8–12% is not uncommon and often goes unnoticed until profitability has already declined.
Limited alignment between headquarters and local markets compounds the issue. Local teams negotiate in isolation with limited HQ visibility, reducing global leverage, creating inconsistent terms, and preventing systematic partner management. Individually, each issue represents an inefficiency; together, they form a structural barrier to performance.
From Fragmentation to Discipline: What Partner Optimization Looks Like
Transforming partner management requires structure, transparency, and accountability across every layer of the indirect channel. Four priorities consistently stand out.
1. Partner rating and selection. Optimization begins with transparency. A unified scorecard combining financial performance with compliance, access, and reputation provides an objective view of the partner base. Consolidating data across markets enables fact-based comparisons, while clear segmentation and entry and exit criteria ensure resources are directed toward high-value distributors and underperformers are phased out.
2. Go-to-market redesign. Redesigning GTM models eliminates overlaps and closes coverage gaps. Market-by-market analysis highlights where consolidation improves efficiency and where selective expansion captures growth. Tailored structures balance direct and indirect presence, while governance mechanisms clarify HQ and local roles, ensuring consistent execution with flexibility for market dynamics.
3. Contracting excellence. Contracts must shift from static agreements to tools that actively drive performance. Standardized playbooks, performance-linked clauses, and regular review cycles embed discipline and align incentives with long-term profitability. Training local teams ensures consistent negotiation and execution across markets.
4. Pricing discipline. Pricing is often the greatest source of leakage. Consolidating discounts and rebates creates transparency, while performance-linked models tie concessions to value delivered. Negotiation tools and dashboards provide real-time visibility into margins and compliance, protecting profitability and strengthening leverage with distributors.
The Impact of Disciplined Partner Optimization
When managed with structure and discipline, indirect networks shift from being a source of leakage to a driver of profitability and resilience. Companies gain transparency into performance, eliminate overlaps in coverage, and align partner incentives with long-term goals. Pricing discipline restores negotiating power and protects margins, while governance mechanisms ensure consistency across HQ and local markets. Together, these levers deliver margin recovery of 5–7%, efficiency gains of 15–20%, and annual margin improvement of 10–12%, while building confidence to manage complexity with agility.
Looking Ahead
Across the pharmaceutical industry, indirect sales partners are no longer peripheral actors but determinants of competitiveness. Those who continue to treat them as inherited structures will face persistent inefficiency and margin erosion. Those who approach them as strategic assets will unlock sustainable advantage.
The path forward is clear: evaluate partners with transparency, design GTM models deliberately, embed discipline in contracts, enforce rigor in pricing, and balance governance between headquarters and local teams. These principles are not about adding bureaucracy, but about creating the clarity and alignment needed to make decisive commercial choices.
In a fragmented European market where every percentage point of margin matters, disciplined partner optimization is the difference between defending market share and expanding profitably. For leaders willing to act, it becomes a foundation of growth, resilience, and long-term competitive strength.
Get in touch now
Email: office@eendigo-ops.com
Website: www.eendigo.com
LinkedIn: www.linkedin.com/company/eendigo